Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy.

Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, Lieberman JA, Marder SR, Maruff P, McMahon RP, Seidman LJ, Peykamian MA.

Schizophr Res. 2015 May;164(1-3):136-42. doi: 10.1016/j.schres.2015.01.041. Epub 2015 Feb 24.

PMID:
25728831
2.

A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease.

Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP.

Curr Alzheimer Res. 2014 Jan;11(1):47-58.

PMID:
24359500
3.

The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H₃ receptor antagonist in patients with mild to moderate Alzheimer's disease: a preliminary investigation.

Nathan PJ, Boardley R, Scott N, Berges A, Maruff P, Sivananthan T, Upton N, Lowy MT, Nestor PJ, Lai R.

Curr Alzheimer Res. 2013 Mar;10(3):240-51.

PMID:
23521503
4.

Quantitative subregional distribution of serotonin1A receptors and serotonin transporters in the human dorsal raphe.

Stockmeier CA, Shapiro LA, Haycock JW, Thompson PA, Lowy MT.

Brain Res. 1996 Jul 15;727(1-2):1-12.

PMID:
8842377
5.

Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats.

Lowy MT, Wittenberg L, Yamamoto BK.

J Neurochem. 1995 Jul;65(1):268-74.

PMID:
7790870
7.
8.
9.
10.

Adrenal size is increased in multiple sclerosis.

Reder AT, Makowiec RL, Lowy MT.

Arch Neurol. 1994 Feb;51(2):151-4.

PMID:
8304840
11.
12.

Serum prolactin levels in active multiple sclerosis and during cyclosporin treatment.

Reder AT, Lowy MT.

J Neurol Sci. 1993 Jul;117(1-2):192-6.

PMID:
8410056
13.

Interferon-beta treatment does not elevate cortisol in multiple sclerosis.

Reder AT, Lowy MT.

J Interferon Res. 1992 Jun;12(3):195-8.

PMID:
1640121
14.

Effects of intravenous and oral dexamethasone on selected lymphocyte subpopulations in normal subjects.

Chiappelli F, Gormley GJ, Gwirstman HE, Lowy MT, Nguyen LD, Nguyen L, Esmail I, Strober M, Weiner H.

Psychoneuroendocrinology. 1992 May-Jul;17(2-3):145-52.

PMID:
1359598
15.

Kainic acid-induced decrease in hippocampal corticosteroid receptors.

Lowy MT.

J Neurochem. 1992 Apr;58(4):1561-8.

PMID:
1312577
16.

Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder.

Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW.

Biol Psychiatry. 1991 Nov 15;30(10):1031-48. Review.

PMID:
1661614
17.

Corticosterone regulation of brain and lymphoid corticosteroid receptors.

Lowy MT.

J Steroid Biochem Mol Biol. 1991 Aug;39(2):147-54.

PMID:
1888673
18.

Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder.

Yehuda R, Lowy MT, Southwick SM, Shaffer D, Giller EL Jr.

Am J Psychiatry. 1991 Apr;148(4):499-504.

PMID:
2006697
19.
20.

Reserpine-induced DST nonsuppression in rats.

Lowy MT, Nash JF Jr, Meltzer HY.

Biol Psychiatry. 1990 Mar 1;27(5):546-8. No abstract available.

PMID:
1968770
22.
23.

Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).

Lowy MT, Nash JF Jr, Meltzer HY.

Eur J Pharmacol. 1989 Apr 12;163(1):157-61.

PMID:
2472965
24.

Plasma cortisol and depression in pathological gamblers.

Ramirez LF, McCormick RA, Lowy MT.

Br J Psychiatry. 1988 Nov;153:684-6.

PMID:
3255458
25.

Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test.

Lowy MT, Reder AT, Gormley GJ, Meltzer HY.

Biol Psychiatry. 1988 Oct;24(6):619-30.

PMID:
3262379
26.

Platelet MAO activity and the cortisol response to dexamethasone in major depression.

Meltzer HY, Lowy MT, Locascio JJ.

Biol Psychiatry. 1988 Jun;24(2):129-42.

PMID:
3390495
27.
28.

Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy.

Reder AT, Lowy MT, Meltzer HY, Antel JP.

Neurology. 1987 May;37(5):849-53.

PMID:
3033547
29.

Dexamethasone bioavailability: implications for DST research.

Lowy MT, Meltzer HY.

Biol Psychiatry. 1987 Mar;22(3):373-85.

PMID:
3814685
30.

5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients.

Koyama T, Lowy MT, Meltzer HY.

Am J Psychiatry. 1987 Mar;144(3):334-7.

PMID:
2435178
31.

The hypothalamic-pituitary-adrenal axis in depression.

Meltzer HY, Lowy MT, Koenig JI.

Adv Biochem Psychopharmacol. 1987;43:165-82. No abstract available.

PMID:
3035885
32.

Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test.

Gormley GJ, Lowy MT, Reder AT, Hospelhorn VD, Antel JP, Meltzer HY.

Am J Psychiatry. 1985 Nov;142(11):1278-84.

PMID:
4061686
33.

Opioid modulation of feeding behavior following forced swimming exercise in male rats.

Davis JM, Lamb DR, Lowy MT, Yim GK, Malven PV.

Pharmacol Biochem Behav. 1985 Nov;23(5):701-7.

PMID:
2934748
34.

Effects of 2% sodium chloride imbibition on various opiate related hyperphagic conditions.

Bryant HU, Lowy MT, Malven PV, Steele TD, Yim GK.

Pharmacol Biochem Behav. 1985 Sep;23(3):391-5.

PMID:
2864702
35.

Experimental dissociation of food intake and plasma beta-endorphin following 2-deoxy-D-glucose in rats.

Lowy MT, Davis JM, Lamb DR, Malven PV, Yim GK.

Peptides. 1985 May-Jun;6(3):569-73.

PMID:
2933639
36.

Hypercortisolism and depression.

Lowy MT, Reder AT, Meltzer HY.

N Engl J Med. 1985 Mar 21;312(12):791-2. No abstract available.

PMID:
3871910
37.

Naltrexone fails to suppress spontaneous locomotor activity in hamsters.

Lowy MT, Sangiah S, Yim GK.

Pharmacol Biochem Behav. 1985 Mar;22(3):399-401.

PMID:
3991756
38.

Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone.

Lowy MT, Reder AT, Antel JP, Meltzer HY.

Am J Psychiatry. 1984 Nov;141(11):1365-70.

PMID:
6333828
39.

Opioids, feeding, and anorexias.

Yim GK, Lowy MT.

Fed Proc. 1984 Nov;43(14):2893-7. Review.

PMID:
6149154
40.

Central and peripheral anti-inflammatory actions by clonidine and a structurally related imidazoline analog.

Holsapple MP, Malave A, Lowy MT, Yim GK.

J Pharmacol Exp Ther. 1984 May;229(2):399-403.

PMID:
6716264
41.

Stimulation of food intake following opiate agonists in rats but not hamsters.

Lowy MT, Yim GK.

Psychopharmacology (Berl). 1983;81(1):28-32.

PMID:
6415728
42.

Relationship between plasma concentrations of immunoreactive beta-endorphin and food intake in rats.

Davis JM, Lowy MT, Yim GK, Lamb DR, Malven PV.

Peptides. 1983 Jan-Feb;4(1):79-83.

PMID:
6306619
43.

Opioid modulation of appetite.

Morley JE, Levine AS, Yim GK, Lowy MT.

Neurosci Biobehav Rev. 1983 Summer;7(2):281-305.

PMID:
6136016
44.

Drinking, but not feeding, is opiate-sensitive in hamsters.

Lowy MT, Yim GK.

Life Sci. 1982 May 10;30(19):1639-44.

PMID:
7047964
45.

Stereoselective effects of opiate agonists and antagonists on ingestive behavior in rats.

Lowy MT, Starkey C, Yim GK.

Pharmacol Biochem Behav. 1981 Oct;15(4):591-6.

PMID:
7291263
46.

The anorexic effect of naltrexone is independent of its suppressant effect on water intake.

Lowy MT, Yim GK.

Neuropharmacology. 1981 Sep;20(9):883-6. No abstract available.

PMID:
7290360
47.

Selective reduction by dexamethasone of stress-related hyperphagias.

Lowy MT, Yim GK.

Life Sci. 1980 Dec 22-29;27(25-26):2553-8. No abstract available.

PMID:
7012511
48.

Naloxone reduction of stress-related feeding.

Lowy MT, Maickel RP, Yim GK.

Life Sci. 1980 Jun 16;26(24):2113-8. No abstract available.

PMID:
6993827
49.

Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.

Nichols DE, Woodard R, Hathaway BA, Lowy MT, Yom KW.

J Med Chem. 1979 Apr;22(4):458-60.

PMID:
430485
50.

Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.

Pfister WR, Noland V, Lowy MT, Nichols DE, Yim GK.

Commun Psychopharmacol. 1978;2(4):287-95. No abstract available.

PMID:
729354

Supplemental Content

Support Center